California storm leaves thousands without power and prompts evacuation orders and fears of flooding
Another round of heavy rain and snow fueled by atmospheric rivers will pound the drought-stricken state for the next several days.
Biden says he intends to visit the U.S.-Mexico border for first time since taking office
The president, who didn’t provide further details, is scheduled to attend the North American Leaders’ Summit in Mexico City next week.
XBB.1.5 omicron subvariant is the most transmissible version of Covid yet, WHO says
The WHO does not have any data yet on the severity of XBB.1.5, but there’s no indication it makes people sicker than previous subvariants, top official said.
California braces for powerful atmospheric river storm
The new storm in California is part of a series of atmospheric river storms that climate scientists forecast will continue this month.
GM reclaims title as America’s top automaker after a 2.5% jump in sales last year
GM said Wednesday it sold 2.27 million vehicles in the U.S. in 2022, up by 2.5% for the year.
Job openings hold strong despite rate hikes; manufacturing in contraction
Demand for employment remained high in November as companies looked for workers to fill positions despite worries of a looming recession.
Rivian stock hits new 52-week low after the automaker misses 2022 production target
Rivian said it produced 24,337 vehicles last year, slightly missing its 25,000 target.
Shares of Charles Schwab could rise 20% as interest rates peak, Goldman Sachs says in upgrade
The company has an “under-appreciated earnings and capital return opportunities,” according to Goldman Sachs.
Mastermind of ‘Varsity Blues’ college admissions scheme sentenced to more than 3 years in prison
William Rick Singer allegedly raked in more than $25 million from his clients and paid bribes totaling more than $7 million in the nationwide college admissions scandal.
Bank of America upgrades Merck, says pharma giant will outperform even as macro pressures mount
The firm expects further upside for the pharmaceutical stock, which jumped roughly 45% in 2022.
